Combination antitumor therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9198893
APP PUB NO 20110136756A1
SERIAL NO

12993140

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to methods of treating cancers that are responsive to antimetabolite or antimitotic anti-cancer agents. The methods involve the use of at least one anti-cancer agent selected from antimetabolite anti-cancer agents, antimitotic anti-cancer agents, and combinations thereof, and a superoxide dismutase mimetic to potentiate the therapeutic effect of the anti cancer agent(s).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GALERA LABS LLC1100 CORPORATE SQUARE DRIVE SUITE 223 CREVE COEUR MO 63132

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beardsley, Robert A University City, US 22 111
Keene, Jeffery L St. Louis, US 18 102
Riley, Dennis P St. Louis, US 70 843

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00